Switzerland· 61663004
Oxaliplatin Sandoz 50 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
A oxaliplatin product containing oxaliplatinum, registered in Switzerland by Sandoz Pharmaceuticals AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Oxaliplatin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01XA03 (oxaliplatin), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Oxaliplatin · ATC L01XA03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of oxaliplatin costs, country by country.
Normalised to the WHO defined daily dose (11 mg), so markets compare like for like.
- Switzerland: $24.21 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Oxaliplatin · price per daily dose (11 mg)
USD · FX 28 Sept 2026
- CH Switzerland$24.21
The record
At a glance
Swissmedic (Switzerland)- Active substance
- oxaliplatinum
- Manufacturer
- Sandoz Pharmaceuticals AG
- Country
- Switzerland (CH)
- ATC code
- L01XA03
- ATC class
- Oxaliplatin
- Defined daily dose
- 11 mg, P
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680616630049Vial 1 StkCHF 99.8
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
740 interactions on record for oxaliplatin.
Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxaliplatin · interactions on record
740 records
- 101 severe
- 453 moderate
- 1 minor
- 185 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxaliplatin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesoxaliplatinShandong New Time Pharmaceutical Co., Ltd.
- SpainELOXATIN 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSIONSanofi Aventis S.A.
- United KingdomEloxatin 100mg powder for solution for infusion vialsSanofi
- CzechiaOXALIPLATIN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- BelgiumEloxatin 5 mg/mlSanofi Belgium
- FinlandEloxatinsanofi-Aventis Oy
- GermanyEloxatinSanofi-Aventis Deutschland Gmbh
- FranceELOXATINE 5 mg/ml, solution à diluer pour perfusionSANOFI WINTHROP INDUSTRIE
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ebeoxal, Oxaliplatin Accord
- Belgium · Eloxatin, Oxaliplatin Accord Healthcare
- Bulgaria · Оксалиплатин Акорд, Оксалиплатин Булгермед
- Cyprus · Oxaliplatin
- Czechia · Oxaliplatin Accord, Oxaliplatin Agmed
- Germany · Eloxatin, Medoxa
- Denmark · Oxaliplatin Accord, Oxaliplatin Actavis
- Estonia · Oxaliplatin Accord, Oxaliplatin Kabi
- Spain · Oxaliplatino Accord, Oxaliplatino Aurovit
- Finland · Oxaliplatin Accord
- France · Dacplat, Eloxatine
- United Kingdom (Northern Ireland) · Oxaliplatin Accord Healthcare, Oxaliplatin Amarox
- Greece · Elatofen, Oxaliplatin Deltapharma
- Croatia · Oksaliplatin Kalceks, Oxaliplatin Kabi
- Hungary · Oxaliplatin Accord, Oxaliplatin Kabi
- Ireland · Oxaliplatin Accord Healthcare Ireland, Oxaliplatin Fresenius Kabi Deutschland
- Iceland · Oxaliplatin Actrevo, Oxaliplatin Teva
- Italy · Oxaliplatino Accord, Oxaliplatino Aurobindo
- Lithuania · Oxaliplatin Accord, Oxaliplatin Kabi
- Luxembourg · Eloxatin, Oxaliplatine Fresenius Kabi
- Latvia · Oxaliplatin Accord, Oxaliplatin Kabi
- Malta · Oxaviatin
- Netherlands · Oxaliplatin Hikma, Oxaliplatine Accord
- Norway · Oksaliplatin Sun, Oxaliplatin Fresenius Kabi
- Poland · Oxaliplatin Ebewe, Oxaliplatin Eugia
- Portugal · Oxaliplatina Accord, Oxaliplatina Aurovitas
- Romania · Oxaliplatin Accord, Oxaliplatin Aqvida Gmbh
- Sweden · Oxaliplatin Accord, Oxaliplatin Eugia
- Slovenia · Oksaliplatin Kabi, Oksaliplatin Sandoz
- Slovakia · Oxaliplatin Agmed, Oxaliplatin Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9828d9e-3b7b-4b9a-93af-06a2f70b2833 GET /v1/drugs/e9828d9e-3b7b-4b9a-93af-06a2f70b2833?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "oxaliplatinum 50 mg",
"valid_from": "2017-06-01",
"limitations": null,
"galenic_form": "Inf Konz 50 mg/10ml",
"therapeutic_area": null,
"sl_inclusion_date": "2011-07-01",
"self_retention_pct": 10
}See everything about oxaliplatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.